These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11487337)
41. Monopropionate analogues of DOTA4- and DTPA5-: kinetics of formation and dissociation of their lanthanide(III) complexes. Balogh E; Tripier R; Fousková P; Reviriego F; Handel H; Tóth E Dalton Trans; 2007 Aug; (32):3572-81. PubMed ID: 17680048 [TBL] [Abstract][Full Text] [Related]
42. Conformational characterization of lanthanide(III)-DOTA complexes by ab initio investigation in vacuo and in aqueous solution. Cosentino U; Villa A; Pitea D; Moro G; Barone V; Maiocchi A J Am Chem Soc; 2002 May; 124(17):4901-9. PubMed ID: 11971741 [TBL] [Abstract][Full Text] [Related]
43. Ga(III) chelates of amphiphilic DOTA-based ligands: synthetic route and in vitro and in vivo studies. Fontes A; Prata MI; Geraldes CF; André JP Nucl Med Biol; 2011 Apr; 38(3):363-70. PubMed ID: 21492785 [TBL] [Abstract][Full Text] [Related]
44. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions. Lewis MR; Shively JE Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of a novel decadentate ligand DEPA. Chong HS; Lim S; Baidoo KE; Milenic DE; Ma X; Jia F; Song HA; Brechbiel MW; Lewis MR Bioorg Med Chem Lett; 2008 Nov; 18(21):5792-5. PubMed ID: 18845437 [TBL] [Abstract][Full Text] [Related]
46. Rapid and efficient production of radiolabeled antibody conjugates using vacuum diafiltration guided by mathematical modeling. Bartlett DW; Colcher D; Raubitschek AA Bioconjug Chem; 2008 Sep; 19(9):1927-37. PubMed ID: 18720981 [TBL] [Abstract][Full Text] [Related]
47. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules. Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687 [TBL] [Abstract][Full Text] [Related]
48. An NMR and DFT investigation on the conformational properties of lanthanide(III) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate analogues containing methylenephosphonate pendant arms. Purgel M; Baranyai Z; de Blas A; Rodríguez-Blas T; Bányai I; Platas-Iglesias C; Tóth I Inorg Chem; 2010 May; 49(9):4370-82. PubMed ID: 20369836 [TBL] [Abstract][Full Text] [Related]
49. Long-range-distance NMR effects in a protein labeled with a lanthanide-DOTA chelate. Vlasie MD; Comuzzi C; van den Nieuwendijk AM; Prudêncio M; Overhand M; Ubbink M Chemistry; 2007; 13(6):1715-23. PubMed ID: 17115462 [TBL] [Abstract][Full Text] [Related]
51. Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy. Peterson JJ; Pak RH; Meares CF Bioconjug Chem; 1999; 10(2):316-20. PubMed ID: 10077483 [TBL] [Abstract][Full Text] [Related]
52. Efficient synthesis and evaluation of bimodal ligand NETA. Chong HS; Song HA; Birch N; Le T; Lim S; Ma X Bioorg Med Chem Lett; 2008 Jun; 18(11):3436-9. PubMed ID: 18445528 [TBL] [Abstract][Full Text] [Related]
53. DOTA analogues with a phosphinate-iminodiacetate pendant arm: modification of the complex formation rate with a strongly chelating pendant. Procházková S; Kubíček V; Böhmová Z; Holá K; Kotek J; Hermann P Dalton Trans; 2017 Aug; 46(31):10484-10497. PubMed ID: 28758669 [TBL] [Abstract][Full Text] [Related]
54. Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds. Wängler C; Wängler B; Eisenhut M; Haberkorn U; Mier W Bioorg Med Chem; 2008 Mar; 16(5):2606-16. PubMed ID: 18065226 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents. Chong HS; Ma X; Lee H; Bui P; Song HA; Birch N J Med Chem; 2008 Apr; 51(7):2208-15. PubMed ID: 18345610 [TBL] [Abstract][Full Text] [Related]
56. Comparative evaluation of Satpati D; Sharma R; Sarma HD; Dash A Chem Biol Drug Des; 2018 Mar; 91(3):781-788. PubMed ID: 29130625 [TBL] [Abstract][Full Text] [Related]
57. Influence of chelate conjugation on a newly identified tumor-targeting peptide. Mier W; Zitzmann S; Krämer S; Reed J; Knapp EM; Altmann A; Eisenhut M; Haberkorn U J Nucl Med; 2007 Sep; 48(9):1545-52. PubMed ID: 17704241 [TBL] [Abstract][Full Text] [Related]
58. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046 [TBL] [Abstract][Full Text] [Related]
59. H4octapa: an acyclic chelator for 111In radiopharmaceuticals. Price EW; Cawthray JF; Bailey GA; Ferreira CL; Boros E; Adam MJ; Orvig C J Am Chem Soc; 2012 May; 134(20):8670-83. PubMed ID: 22540281 [TBL] [Abstract][Full Text] [Related]
60. TmDOTA-: a sensitive probe for MR thermometry in vivo. Zuo CS; Mahmood A; Sherry AD J Magn Reson; 2001 Jul; 151(1):101-6. PubMed ID: 11444943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]